Based on the GME predictions, the Global Immunofluorescence Assay Market would grow with a CAGR value of 6.25%and cross USD 3.50 billion by 2026. Immunofluorescence Assay (IFA) is also known as a usual virologic technique used to identify the existence of antibodies in infected cells. The demand for Immunofluorescence Assay is indirectly related to the rate of diseases
Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth TOC on " Immunofluorescence Assay- Forecast to 2026"
https://www.globalmarketestimates.com/market-report/global-immunofluorescence-assay-market-2790
By Product (Antibodies, Reagents, Kits, Instruments, Consumables, and Accessories), By Type (Indirect Immunofluorescence, Direct Immunofluorescence), By Disease (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Hospitals & Diagnostics Centers), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Key Market Insights
· An increase in chronic illness worldwide, especially during the COVID 19 pandemic required the use of Immunofluorescence Assay for testing antigens.
· Support from various government schemes for promoting research and development
· Various competitors in the Immunofluorescence market include Abcam plc, Werfen Company, Bio-Rad Laboratories, Inc, MaxVision Biosciences Inc, AESKU GROUP GmbH, Merck KGaA (Germany), Elabscience, Inc., EpiGentek Group, Cell Signaling Technology, Inc. (US), Abnova Corporation, MEDIPAN GmbH (Germany), J. Mitra& Co. Pvt. Ltd. (India), Sino Biological, Inc. (China), Cellabs (Australia), Danaher Corporation (US), Zyagen, Inc. (US), Agilent Technologies, Enzo Biochem, Inc. (US), Bruker Corporation, Becton, Dickinson, and Company (US), Thermo Fisher Scientific, Inc, Nikon Corporation, Olympus Corporation and PerkinElmer Inc amongst others..
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-immunofluorescence-assay-market-2790
Product Outlook (Revenue, USD Million, 2021-2026)
· Antibodies
· Reagents
· Kits
· Instruments
· Consumables and Accessories
Type Outlook (Revenue, USD Million, 2021-2026)
· Indirect Immunofluorescence
· Direct Immunofluorescence
Disease Outlook (Revenue, USD Million, 2021-2026)
· Cancer
· Infectious Diseases
· Cardiovascular Diseases
· Autoimmune Diseases
· Other Diseases
End-User Outlook (Revenue, USD Million, 2021-2026)
· Academic & Research Institutes
· Pharmaceutical & Biotechnology Companies
· Contract Research Organizations
· Hospitals & Diagnostic Centers
Regional Outlook (Revenue, USD Million, 2021-2026)
North America
The U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Rest of APAC
Central & South America
Brazil
Argentina
Rest of CSA
Middle East & Africa
Saudi Arabia
UAE
Rest of MEA
Contact: Tracy Simon
Email address: tracy.simon@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
Industries
Reports
Services
Newsroom
Next-Gen Expertise About Us
Contact Us
Blog
Category Healthcare
Format
Request Free
Sample
Buy Now
Immunofluorescence Assay Market: Insights
Immunofluorescence Assay (IFA) is also known as a usualvirologic technique used to identify the
existence of antibodies in infected cells. Antibodies act as a guard and defender against any foreign
invaders and signals the immune system to act on them. A higher rate of antibodies requires a
healthier immune system. Therefore the demand for immunofluorescence assay is indirectly related to
the rate of diseases. Specialized kits and instruments help ease put the process of testing and provide
a degree of convenience to its end users. Higher the rate of ill people, the more the demand for
immunofluorescence assay. The products are widely used in different medical facilities such as
hospitals, pharmaceutical & bio companies, academic and research institutes, and medical research
organizationsamong others.
During COVID 19 pandemic the need for immunofluorescence assay increased immensely globally, as
they were used to detect the corona antigens. This along with their hiked-up usage for testing of
COVID within patients and potential patients helped
in skyrocketing the demand for
immunofluorescence assay globally during the forecast duration. As more and more companies
indulge in vaccine testing stages, moving ahead with human subject experiments requires the usage
of immunofluorescence assay for better results in vaccine formation.
Global Immunofluorescence Assay Market
Global Immunofluorescence Assay Market Size, Trends, and Analysis - Forecasts To 2026 By Product (Antibodies,
Reagents, Kits,
Instruments, Consumables, and Accessories), By Type (Indirect Immunofluorescence, Direct
Immunofluorescence) By Disease (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Other
Diseases), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research
Organizations, Hospitals & Diagn